Investigation Reveals Deep Flaws in FDA Drug Approval Process, Raising Concerns Over Public Safety** A recent investigative report has uncovered alarming findings regarding the ...

(Reuters) -British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to ...

The FDA issued the recall for Enoki mushrooms - popular in stir fries and hot pots - that were sold in seven ounce green ...

In his first 100 days as commissioner of the Food and Drug Administration, Marty Makary has made a handful of splashy ...

On July 10, 2025, the Food and Drug Administration (FDA) announced that it had published more than 200 complete response letters (CRLs), in ...

How nicotine pouches are causing a rise in poisoning cases among young children and what parents can do to prevent it ...

Zimmer Biomet Holdings Inc. and Monogram Technologies Inc., an orthopedic robotics company, have announced that they have ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced FDA approval for an update to its Varipulse platform's irrigation flow ...

(HealthDay News) — The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications ...

The FDA has removed the REMS program requirements for embryofetal toxicity risk from all endothelin receptor antagonist medications.

Meanwhile, Bloomberg reports that the FDA may offer to fast-track drug reviews for companies that lower their U.S drug prices. Also: a billion-dollar backlog of delayed grants at HHS, and more.

The Food and Drug Administration (FDA), in collaboration with the National Institutes of Health (NIH), hosted a workshop ...